Fp Chem Structure (Airduo Respiclick N208799 1)
Airduo Respiclick Powder, Metered
Product Images NDC 59310-805
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Airduo Respiclick (NDC 59310-805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Respiratory, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 8 (Airduo Respiclick N208799 10)
Teva Logo (Airduo Respiclick N208799 11)
Teva Logo (Airduo Respiclick N208799 12)
Figure A (Airduo Respiclick N208799 13)
The description is "Dose counter".*
Figure B (Airduo Respiclick N208799 14)
This text suggests that there is a inhaler which is capable of delivering 60 doses, and that it has been used up completely as it is now empty and has delivered 0 doses left.*
Figure C (Airduo Respiclick N208799 15)
Figure D (Airduo Respiclick N208799 16)
Figure E (Airduo Respiclick N208799 17)
Figure F (Airduo Respiclick N208799 18)
Figure G (Airduo Respiclick N208799 19)
Salmeterol Chem Structure (Airduo Respiclick N208799 2)
Figure H (Airduo Respiclick N208799 20)
Teva Logo (Airduo Respiclick N208799 21)
Ndc 59310-805-06 Carton (55 mcg/ 14 mcg)
This is a description of a medication called RespiClick 55/14. It is an inhalation powder containing fluticasone propionate and salmeterol. The medication comes with a dose counter and can be used for oral inhalation only, with a total of 40 metered inhalations.*
113 Mcg/ 14 Mcg Carton (NDC 59310-812-06)
This appears to be the product label for a prescription inhalation powder containing fluticasone propionate and salmeterol. It includes the NDC number for the product and dosage information.*
232 Mcg/ 14 Mcg Carton (NDC 59310-822-06)
This is a description of a medication with the product ID of IDC 59310-822-06 or NDC 59310-822-06. It is an inhalation powder which contains fluticasone propionate in 232mg dosage and salmeterol in 14mg dosage. The medication should only be taken via oral inhalation and is designed for 60 metered inhalations.*
Figure 1 (Airduo Respiclick N208799 3)
This appears to be a table showing data from two clinical trials comparing the effectiveness of two medications for inhalation (FpMOPI and FpOPI) in different doses. The table includes information on the treatment group, the dosage, and the number of participants. There is also information on the metered dose calculation based on phase 2b formulation compositions. The text is not-readable.*
Figure 2 (Airduo Respiclick N208799 4)
Figure 3 (Airduo Respiclick N208799 5)
This appears to be a chart or table showing different medications or doses being evaluated over the course of several weeks. The medication names mentioned are "AIRDUO RESPICLICK" and "Fluticasone Propionate," as well as a "Placebo" group. The doses or strengths used are listed as "113 meg/14 meg," "55 meg," "S5 mcg/14 mcg," and "113 mcg." The chart appears to track some sort of measurement or symptom, perhaps related to asthma or allergies.*
Figure 4 (Airduo Respiclick N208799 6)
This appears to be a table or chart showing the mean change in FEV (forced expiratory volume) for different medication dosages, including AirDuo Respiklick and Fluticasone Propionate. However, without more context, it is difficult to provide a more detailed description or interpretation.*
Figure 5 (Airduo Respiclick N208799 7)
This is a clinical trial study that evaluates the efficacy of different types of medication on lung function. The medications evaluated include Airduo Respiclick and Fluticasone Propionate in two different doses (113 meg and 55 meg). A placebo group was also included in the study. The study measured the mean change in FEV over a period of 12 weeks. The results are presented in a graph, showing the baseline FEV and the mean change in FEV at week 12 for each medication group as well as the placebo group.*
Figure 6 (Airduo Respiclick N208799 8)
Figure 7 (Airduo Respiclick N208799 9)
This is a chart that compares the mean change in Forced Expiratory Volume (FEV) in liters among different medication groups including AIRDUO RESPICLICK 232 mcg/14 mcg, AIRDUO RESPICLICK 113 mcg/14 mcg, Fluticasone Propionate MDPI 232 mcg, Fluticasone Propionate MDPI 113 mcg, and Placebo, over a course of 12 days. There are different sample sizes for each medication group. No additional information is available.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
